Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
584.00    5.00 (0.86%)
Bid:
582.00
Ask:
585.00
Spread: 3.00 (0.515%)
Market Cap: £849.08m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Financing transactions

22 Jun 2021 08:00

RNS Number : 6715C
SAGA PLC
22 June 2021
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (MAR).

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF SAGA PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

22 June 2021

Saga plc

Financing transactions

Saga plc ("Saga" or "the Group"), the UK's specialist in products and services for people over 50, today announces a number of financing transactions intended to improve its financial flexibility by increasing available liquidity, extending debt maturities and providing greater headroom against covenants.

The transactions, which deliver against Saga's strategic priority to strengthen the balance sheet, are the launch of a roadshow in respect of a £250 million fixed rate guaranteed unsecured bond, the launch of a tender offer in respect of its Existing Bonds (as defined below) with a target acceptance amount of up to £100 million, the £70 million repayment of its term loan and amendments to the covenants in its existing revolving credit facilities. All transactions are contingent on each other.

Proposed offering of GBP denominated fixed rate guaranteed bonds

Saga has mandated Barclays Bank PLC, HSBC Bank plc, Mizuho International plc and NatWest Markets Plc to carry out roadshows in connection with a proposed offering (the "Offering") of £250 million GBP denominated fixed rate guaranteed bonds (the "Bonds") to be fully, unconditionally and irrevocably guaranteed on a joint and several basis by Saga Mid Co Limited and Saga Services Limited (together, the "Guarantors").

The completion of the Offering will be subject to market conditions and further details will be announced in due course. If completed, the proceeds of the Offering will be used by Saga (i) to repay in full its existing term loan, (ii) to fund the settlement of a concurrent Tender Offer (as defined below), and (iii) for general corporate purposes.

Proposed tender offer for Saga's £250,000,000 3.375 per cent notes due 2024

Saga is also announcing its invitation to holders of its £250,000,000 3.375 per cent notes due 12 May 2024 (ISIN: XS1610655950) guaranteed by the Guarantors (the "Existing Bonds") to tender their Existing Bonds for purchase by Saga for up to £100 million in cash (subject to the satisfaction or waiver of certain conditions) (the "Tender Offer"). Barclays Bank PLC and HSBC Bank plc have been mandated as dealer managers in respect of the Tender Offer.

A launch announcement in respect of the Tender Offer will shortly be available on the RIS publication section of the website of the Irish Stock Exchange plc trading as Euronext Dublin (https://direct.euronext.com/Announcements/View-Announcements/RIS-Announcements/) (the "Tender Offer Announcement"). Existing Bondholders should follow the procedures set out in the Tender Offer Announcement in order to partake in the Tender Offer.

Amendment to corporate finance facilities

The Company further announces that it has reached agreement to amend its existing term loan and revolving credit facilities, in order to, among other things, (i) prepay in full and cancel the existing term loan facility using the proceeds of the Offering, and (ii) amend the financial covenants. The specific details of the amendments are shown in the appendix below. 

The person responsible for making this announcement is Vicki Haynes, Group Company Secretary of Saga plc.

For further information please contact:

Saga plc

Mark Watkins Tel: 07738 777 479

Finance Director, Treasury Email: mark.watkins@saga.co.uk

 

Emily Roalfe Tel: 07732 093 007

Head of Investor Relations Email: Emily.roalfe@saga.co.uk

 

Headland Consultancy

Susanna Voyle Tel: 07980 894 557

Will Smith Tel: 07872 350 428

Tel: 020 3805 4822

Email: saga@headlandconsultancy.com

 

Important Notice

This announcement has been issued by and is the sole responsibility of Saga. This announcement is not an offering document or an equivalent and investors should not subscribe for, or otherwise purchase, acquire, sell or dispose of any of the securities referred to in this announcement except on the basis of the information contained in the listing particulars to be published by Saga in connection with the Issue and/or the tender offer memorandum available to Existing Bondholders in connection with the Tender Offer. The information contained in this announcement is for background purposes only and does not purport to be full or complete.

This announcement shall not constitute an offer of securities for sale in the United States. The Bonds have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state of the United States or any other jurisdiction and the securities may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state or local securities laws.

This announcement is for information purposes only and is addressed to and directed only at(i) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), (ii) persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) other persons to whom they may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). This announcement must not be acted on or relied on in the United Kingdom, by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons in the United Kingdom and will be engaged in only with relevant persons.

Appendix

Revolving credit facilities

The covenants within the Group's revolving credit facilities have been amended as follows:

 

Leverage ratio

(excluding Cruise)

Interest cover

 

Old

New

Old

New

31 July 2021

4.75x

4.75x

1.25x

1.25x

31 October 2021*

4.75x

4.75x

1.25x

1.25x

31 January 2022

4.25x

4.25x

1.50x

1.25x

31 July 2022

3.00x

3.75x

3.50x

2.00x

31 January 2023

3.00x

3.75x

3.50x

2.50x

31 July 2023 and onwards

3.00x

3.00x

3.50x

3.50x

* Quarterly covenants are only tested if leverage is above 4.0x times at the previous covenant test date. This requirement ceases on 31 January 2022.

 

In addition, the following amendments have also been made:

· dividends remain restricted while leverage (excluding Cruise) is above 3.0x;

· the Group remains subject to a minimum liquidity requirement of £40 million, which can be met either through cash or undrawn and committed facilities;

· the maximum amount of liquidity that can be used to fund the cruise business has been increased from £55m to £115m; and

· a requirement to prepay the revolving credit facility on 1 March 2024 if the Existing Notes have not been redeemed prior to this date.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFTMFTMTATMFB
Date   Source Headline
26th May 20269:00 amRNSNotice of AGM/ Annual Report and Accounts
12th May 20264:23 pmRNSTotal Voting Rights
8th May 202611:45 amRNSIssue of Equity
23rd Apr 20264:42 pmRNSDirector/PDMR Shareholding
23rd Apr 20264:40 pmRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSPreliminary results for the year ended 31 Jan 2026
23rd Mar 20261:59 pmRNSCommittee Changes
3rd Mar 20267:00 amRNSAppointment of Joint Corporate Brokers
27th Feb 20264:00 pmRNSDirectorate change
29th Jan 20267:00 amRNSTrading Update
16th Dec 20257:00 amRNSSaga and Ageas Insurance partnership goes live
30th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 202510:15 amRNSDirector/PDMR Shareholding
24th Sep 20257:00 amRNS2025-26 interim results statement
15th Jul 20259:00 amRNSTotal Voting Rights
14th Jul 20257:00 amRNSSaga Money launches partnership with NatWest
9th Jul 202512:00 pmRNSCommittee changes
9th Jul 202511:49 amRNSIssue of Equity
1st Jul 20253:57 pmRNSHolding(s) in Company
1st Jul 20252:09 pmRNSAcromas Insurance Company Limited Completion
26th Jun 20251:49 pmRNSDirector/PDMR Shareholding
24th Jun 20251:13 pmRNSResult of AGM
24th Jun 20259:02 amRNSDirector Declaration
24th Jun 20257:00 amRNSAGM Trading Update
29th May 20252:38 pmRNSDirector/PDMR Shareholding
20th May 20259:00 amRNSNotice of AGM
11th Apr 202511:00 amRNSHolding(s) in Company
10th Apr 20257:30 amRNSDirector/PDMR Shareholding
9th Apr 20253:54 pmRNSDirector/PDMR Shareholding
9th Apr 20257:01 amRNSDirectorate Change
9th Apr 20257:00 amRNSFinal Results
13th Mar 20258:00 amRNSDirector Declaration
28th Feb 20257:00 amRNSRepayment of corporate debt and new draw down
12th Feb 20258:00 amRNSDirector Declaration
30th Jan 20257:01 amRNSTrading Update
30th Jan 20257:00 amRNSSaga successfully refinances corporate debt
16th Dec 20247:00 amRNSSaga and Ageas agree new Insurance partnership
10th Dec 20243:57 pmRNSDirector Declaration
24th Oct 20247:35 amRNSDirector Declaration
24th Oct 20247:35 amRNSCorrection - Director Declaration
11th Oct 20247:00 amRNSInterim results for the six months ended 31 July
11th Oct 20247:00 amRNSSaga and Ageas in exclusive negotiations
2nd Oct 20247:00 amRNSResponse to Media Coverage
1st Oct 20244:23 pmRNSDelay to publication of H1 2024 results
1st Oct 20248:59 amRNSDirector Declaration
9th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 20243:00 pmRNSCorrection - Result of AGM
25th Jun 20242:19 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Trading Update
12th Jun 20244:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.